Your browser doesn't support javascript.
loading
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry.
Garrigós, Laia; Saura, Cristina; Martinez-Vila, Clara; Zambelli, Alberto; Bower, Mark; Pistilli, Barbara; Lambertini, Matteo; Ottaviani, Diego; Diamantis, Nikolaos; Lumsden, Ailsa; Pernas, Sonia; Generali, Daniele; Seguí, Elia; Viñas, Gemma; Felip, Eudald; Sanchez, Ana; Rizzo, Gianpiero; Santoro, Armando; Cortellini, Alessio; Perone, Ylenia; Chester, John; Iglesias, Maria; Betti, Marta; Vincenzi, Bruno; Libertini, Michela; Mazzoni, Francesca; Zoratto, Federica; Berardi, Rossana; Guida, Annalisa; Wuerstlein, Rachel; Loizidou, Angela; Sharkey, Rachel; Aguilar Company, Juan; Matas, Marta; Saggia, Chiara; Chiudinelli, Lorenzo; Colomba-Blameble, Emeline; Galazi, Myria; Mukherjee, Uma; Van Hemelrijck, Mieke; Marin, Mar; Strina, Carla; Prat, Aleix; Pla, Helena; Ciruelos, Eva Maria; Bertuzzi, Alexia; Del Mastro, Lucia; Porzio, Giampiero; Newsom-Davis, Thomas; Ruiz, Isabel.
  • Garrigós L; Department of Medical Oncology, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Saura C; Head Breast Cancer Unit, Vall d'Hebron University Hospital and Principal Investigator Breast Group, Vall d'Hebron Institute of Oncology (VHIO), Passeig Vall d'Hebrón 119-129, 08035 Barcelona, Spain.
  • Martinez-Vila C; Department of Oncology, Hospital Althaia Manresa, Barcelona, Spain.
  • Zambelli A; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Bower M; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK.
  • Pistilli B; Department of Medical Oncology, Institute Gustave-Roussy, Villejuif, France.
  • Lambertini M; Department of Medical Oncology, UOC Clinica di Oncologia Medica, IRCCS Policlinico San Martino Hospital, Genoa, Italy.
  • Ottaviani D; Cancer Division, University College London Hospitals, London, UK.
  • Diamantis N; Medical Oncology, Barts Health NHS Trust, London, UK.
  • Lumsden A; Translational Oncology & Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
  • Pernas S; Department of Medical Oncology, Catalan Institute of Oncology, L'Hospitalet, Spain.
  • Generali D; Multidisciplinary Breast Pathology and Translational Research Unit, ASST Cremona, Casalmaggiore, Italy.
  • Seguí E; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain.
  • Viñas G; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain.
  • Felip E; Department of Medical Oncology, Catalan Institute of Oncology, Badalona, Spain.
  • Sanchez A; Department Medical Oncology, Hospital XII de Octubre, Madrid, Spain.
  • Rizzo G; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy.
  • Santoro A; IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Milan, Italy.
  • Cortellini A; Department of Biotechnology and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Perone Y; Medical Oncology, Velindre Cancer Centre, Cardiff, UK.
  • Chester J; Medical Oncology, Velindre Cancer Centre, Cardiff, UK.
  • Iglesias M; Department of Oncology, Hospital Universitario Son Llatzer, Palma de Mallorca, Spain.
  • Betti M; Research Infrastructure, Research and Innovation Department, Azienda Ospedaliera "SS Antonio e Biagio e Cesare Arrigo", Alessandria, Italy.
  • Vincenzi B; Department of Oncology, University "Campus Bio-Medico", Rome, Italy.
  • Libertini M; Medical Oncology Unit, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy.
  • Mazzoni F; Department of Oncology, Careggi University Hospital, Florence, Italy.
  • Zoratto F; Medical Oncology, Santa Maria Goretti Hospital, Latina, Italy.
  • Berardi R; Oncology Clinic, Università Politecnica Delle Marche, Ospedali Riuniti Di Ancona, Ancona, Italy.
  • Guida A; Struttura Complessa di Oncologia Medica e Traslazionale, Azienda Ospedaliera Santa Maria di Terni, Italy.
  • Wuerstlein R; Department of Gynecology and Obstetrics, Breast Center and Gynecological Cancer Center and CCC Munich, University Hospital Munich, Munich, Germany.
  • Loizidou A; Department of Oncology, Institut Jules Bordet, Université Libre de Bruxelles, Belgium.
  • Sharkey R; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK.
  • Aguilar Company J; Department of Medical Oncology, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Matas M; Department of Oncology, Hospital Althaia Manresa, Barcelona, Spain.
  • Saggia C; Department of Translational Medicine, University of Piemonte Orientale, Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy.
  • Chiudinelli L; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Colomba-Blameble E; Department of Medical Oncology, Institute Gustave-Roussy, Villejuif, France.
  • Galazi M; Cancer Division, University College London Hospitals, London, UK.
  • Mukherjee U; Medical Oncology, Barts Health NHS Trust, London, UK.
  • Van Hemelrijck M; Translational Oncology & Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
  • Marin M; Department of Medical Oncology, Catalan Institute of Oncology, L'Hospitalet (Barcelona), Spain.
  • Strina C; Multidisciplinary Breast Pathology and Translational Research Unit, ASST Cremona, Casalmaggiore, Italy.
  • Prat A; Department of Medical Oncology, Hospital Clinic, Barcelona, Spain.
  • Pla H; Department of Medical Oncology, Catalan Institute of Oncology, University Hospital Josep Trueta, Girona, Spain.
  • Ciruelos EM; Department Medical Oncology, Hospital XII de Octubre, Madrid, Spain.
  • Bertuzzi A; IRCCS Humanitas Research Hospital, Humanitas Cancer Center, Milan, Italy.
  • Del Mastro L; Breast Unit, IRCCS Policlinico San Martino Hospital, Genoa, Italy.
  • Porzio G; Medical Oncology Unit, San Salvatore Hospital, L'Aquila, Italy.
  • Newsom-Davis T; Department of Oncology and National Centre for HIV Malignancy, Chelsea and Westminster Hospital, London, UK.
  • Ruiz I; Department of Infectious Diseases, Vall d'Hebron University Hospital, Barcelona, Spain.
Ther Adv Med Oncol ; 13: 17588359211053416, 2021.
Article en En | MEDLINE | ID: mdl-34777582
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Año: 2021 Tipo del documento: Article